tiprankstipranks
Advertisement
Advertisement

AU:CU6 Stock Latest News

Clarity Pharmaceuticals Issues New Shares on Option Exercise in Routine Capital Move
Company AnnouncementsClarity Pharmaceuticals Issues New Shares on Option Exercise in Routine Capital Move
2d ago
CU6
Clarity Pharmaceuticals Seeks ASX Quotation for Small Tranche of New Shares
PremiumCompany Announcements
Clarity Pharmaceuticals Seeks ASX Quotation for Small Tranche of New Shares
2d ago
CU6
Clarity’s PSMA Imaging Agent Shows Superior Performance in Key Prostate Cancer Study
PremiumCompany Announcements
Clarity’s PSMA Imaging Agent Shows Superior Performance in Key Prostate Cancer Study
2d ago
CU6
Clarity Secures Major U.S. Copper-64 Supply Deal with Theragenics
PremiumCompany Announcements
Clarity Secures Major U.S. Copper-64 Supply Deal with Theragenics
8d ago
CU6
Clarity’s 64Cu-SAR-bisPSMA tops standard imaging in prostate cancer trial
PremiumCompany Announcements
Clarity’s 64Cu-SAR-bisPSMA tops standard imaging in prostate cancer trial
16d ago
CU6
Clarity Pharmaceuticals Issues New Shares via Option Exercises, Confirms Regulatory Compliance
PremiumCompany AnnouncementsClarity Pharmaceuticals Issues New Shares via Option Exercises, Confirms Regulatory Compliance
22d ago
CU6
Clarity Pharmaceuticals Seeks ASX Quotation for New Share Issuance
Premium
Company Announcements
Clarity Pharmaceuticals Seeks ASX Quotation for New Share Issuance
22d ago
CU6
Clarity hits Phase III AMPLIFY enrollment goal for prostate cancer imaging agent
Premium
Company Announcements
Clarity hits Phase III AMPLIFY enrollment goal for prostate cancer imaging agent
23d ago
CU6
Clarity Pharmaceuticals Issues Additional Unquoted Employee Options
PremiumCompany Announcements
Clarity Pharmaceuticals Issues Additional Unquoted Employee Options
1M ago
CU6
Clarity Pharmaceuticals Releases 2026 Interim Report Detailing Pipeline and Financial Progress
PremiumCompany Announcements
Clarity Pharmaceuticals Releases 2026 Interim Report Detailing Pipeline and Financial Progress
1M ago
CU6
Clarity Pharmaceuticals Posts Wider Half-Year Loss but Lifts Net Tangible Assets
PremiumCompany Announcements
Clarity Pharmaceuticals Posts Wider Half-Year Loss but Lifts Net Tangible Assets
1M ago
CU6
Clarity flags more prostate cancer patients with no detectable disease in SECuRE trial
PremiumCompany Announcements
Clarity flags more prostate cancer patients with no detectable disease in SECuRE trial
1M ago
CU6
Clarity Advances Late-Stage Radiopharmaceutical Pipeline on Strong Cash Base
PremiumCompany AnnouncementsClarity Advances Late-Stage Radiopharmaceutical Pipeline on Strong Cash Base
2M ago
CU6
Clarity’s SECuRE Prostate Cancer Trial Clears Safety Review and Advances Toward Phase III
Premium
Company Announcements
Clarity’s SECuRE Prostate Cancer Trial Clears Safety Review and Advances Toward Phase III
3M ago
CU6
Clarity Pharmaceuticals Options Lapse, Simplifying Capital Structure
Premium
Company Announcements
Clarity Pharmaceuticals Options Lapse, Simplifying Capital Structure
3M ago
CU6
Clarity’s Prostate Cancer Imaging Data Secures Prime Spot at Major European Urology Congress
PremiumCompany Announcements
Clarity’s Prostate Cancer Imaging Data Secures Prime Spot at Major European Urology Congress
3M ago
CU6
Clarity Wins FDA Backing for Phase III Trial of Cu-64 SARTATE in Neuroendocrine Tumours
PremiumCompany Announcements
Clarity Wins FDA Backing for Phase III Trial of Cu-64 SARTATE in Neuroendocrine Tumours
3M ago
CU6
Clarity Pharmaceuticals Showcases Superior Imaging Agent at ASCO-GI 2026
PremiumCompany Announcements
Clarity Pharmaceuticals Showcases Superior Imaging Agent at ASCO-GI 2026
4M ago
CU6
Clarity Pharmaceuticals Issues Unquoted Equity Securities
PremiumCompany Announcements
Clarity Pharmaceuticals Issues Unquoted Equity Securities
4M ago
CU6
Clarity Pharmaceuticals Issues Unquoted Equity Securities to Employees
PremiumCompany AnnouncementsClarity Pharmaceuticals Issues Unquoted Equity Securities to Employees
4M ago
CU6
JPMorgan Chase & Co. Ceases Substantial Holding in Clarity Pharmaceuticals
Premium
Company Announcements
JPMorgan Chase & Co. Ceases Substantial Holding in Clarity Pharmaceuticals
4M ago
CU6
Clarity Pharmaceuticals Announces Director’s Change in Securities Interest
Premium
Company Announcements
Clarity Pharmaceuticals Announces Director’s Change in Securities Interest
4M ago
CU6

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >